4.7 Review

Sodium bicarbonate, an inorganic salt and a potential active agent for cancer therapy

Journal

CHINESE CHEMICAL LETTERS
Volume 32, Issue 12, Pages 3687-3695

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2021.06.032

Keywords

Sodium bicarbonate; Cancer; Tumor microenvironment; Acidosis; Pharmacology

Funding

  1. National Natural Science Foundation of China [81973261]
  2. Foundation of West China Hospital of Stomatology [RD-02-201903]
  3. West China School/Hospital of Stomatology, Sichuan University [RCDWJS2020-7]

Ask authors/readers for more resources

Cancer poses a serious threat to humans, and traditional therapies may not be sufficient for the increasing demands of patients. NaHCO3 has been found to potentially treat cancer by reversing the acidic tumor microenvironment.
Cancer is a serious threat to humans due to its high mortality. The efforts to fully understand cancer and to fight against it have never been stopped. The traditional therapies, such as surgery, radiotherapy and chemotherapy, are useful but cannot meet the increasing demands of patients. As such, novel approaches against cancer are urgently required. It has been found that the acidic tumor microenvironment plays important roles in promoting the cancer progression. In recent years, sodium bicarbonate (NaHCO3), a simple inorganic salt, has been found to be able to reverse the pH of tumor microenvironment and inhibit the invasion, metastasis, immune evasion, drug resistance and hypoxia of tumor cells. Thus, NaHCO3-based therapy is a potential approach for the treatment of cancer, and the related studies have been increasingly reported. Herein, we aim to provide a comprehensive understanding of the acidic tumor microenvironment and summarize the applications and mechanisms of NaHCO3 in cancer therapy. The combination of NaHCO3 with chemotherapy, immunotherapy or nanoparticles systems is discussed. In addition, the concerns of NaHCO3 in clinical use and the potential ways to use NaHCO3 for cancer therapy are also discussed. (C) 2021 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available